FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Achievwin – US, 2021-08-23 23:35 (466 d 00:51 ago) – Posting: # 22534
Views: 2,064

❝ FDA updated the canonical BE guideline for ANDAs. Draft. :-)

Comments period is open till October 22, 2021, Therefore any issues bothering/benefit ANDA folks can be sent to FDA as comments for consideration.

FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs

More elaborate explanations of each aspect.

Complete thread:

UA Flag
 Admin contact
22,423 posts in 4,694 threads, 1,600 registered users;
17 visitors (1 registered, 16 guests [including 10 identified bots]).
Forum time: 23:27 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz